Cetera Investment Advisers Emergent Bio Solutions Inc. Transaction History
Cetera Investment Advisers
- $44.2 Billion
- Q3 2024
A detailed history of Cetera Investment Advisers transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 384,483 shares of EBS stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
384,483
Previous 126,631
203.62%
Holding current value
$3.41 Million
Previous $863,000
271.96%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EBS
# of Institutions
159Shares Held
33.7MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$34.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$30.2 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$22.2 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$19.8 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$17 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $443M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...